These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 380823

  • 1. Variation among mouse strains in responsiveness to migration inhibitory factor.
    Tagliabue A, Herberman RB, McCoy JL.
    Cell Immunol; 1979 Jul; 45(2):464-8. PubMed ID: 380823
    [No Abstract] [Full Text] [Related]

  • 2. BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG.
    Tracey DE, Wolfe SA, Durdik JM, Henney CS.
    J Immunol; 1977 Sep; 119(3):1145-51. PubMed ID: 330748
    [No Abstract] [Full Text] [Related]

  • 3. Refractoriness to migration inhibitory factor of macrophages of LPS nonresponder mouse strains.
    Tagliabue A, McCoy JL, Herberman RB.
    J Immunol; 1978 Oct; 121(4):1223-6. PubMed ID: 359704
    [Abstract] [Full Text] [Related]

  • 4. Effects of migration inhibiting factor(s) on the in vitro detachment of macrophages.
    Weiss L, Glaves D.
    J Immunol; 1975 Nov; 115(5):1362-5. PubMed ID: 1100729
    [Abstract] [Full Text] [Related]

  • 5. Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains.
    Boraschi D, Meltzer MS.
    Cell Immunol; 1979 Jun; 45(1):188-94. PubMed ID: 378423
    [No Abstract] [Full Text] [Related]

  • 6. Modification of the migration of mouse lymphoid cells by BCG: a factor stimulating T-cell migration.
    Castes M, Borderie N, Orbach-Arbouys S.
    Cell Immunol; 1978 Sep 15; 40(1):37-45. PubMed ID: 359172
    [No Abstract] [Full Text] [Related]

  • 7. Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG).
    Gros P, Skamene E, Forget A.
    J Immunol; 1983 Oct 15; 131(4):1966-72. PubMed ID: 6311901
    [Abstract] [Full Text] [Related]

  • 8. Serum from LPS nonresponder C3H/HeJ mice does not support the formation of functional EAC reagents.
    Hoffmann MK.
    J Immunol; 1978 Aug 15; 121(2):619-21. PubMed ID: 355548
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms in the in vivo release of lymphokines: relationship of high and low responsiveness to other parameters of the immune response.
    Neta R, Salvin SB.
    Infect Immun; 1981 Oct 15; 34(1):160-5. PubMed ID: 6170585
    [Abstract] [Full Text] [Related]

  • 10. Genetic differences in BCG-induced resistance to Schistosoma mansoni are not controlled by genes within the major histocompatibility complex of the mouse.
    Civil RH, Mahmoud AA.
    J Immunol; 1978 Mar 15; 120(3):1070-2. PubMed ID: 344795
    [Abstract] [Full Text] [Related]

  • 11. The requirement for macrophages in the augmentation of natural killer cell activity by BCG.
    Tracey DE.
    J Immunol; 1979 Aug 15; 123(2):840-5. PubMed ID: 222845
    [No Abstract] [Full Text] [Related]

  • 12. Effect of macrophage migration inhibitory factor on migration of allogeneic and xenogeneic macrophages.
    Tsai LC, Chang ZN, Han SH.
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1974 Jun 15; 7(2):99-103. PubMed ID: 4606493
    [No Abstract] [Full Text] [Related]

  • 13. Production of migration inhibitory factor in inbred rats.
    Ruscetti SK, Gill TJ, Salvin SB, Herrman J, Bailie CW.
    Int Arch Allergy Appl Immunol; 1976 Jun 15; 52(1-4):417-21. PubMed ID: 797675
    [Abstract] [Full Text] [Related]

  • 14. In vivo release of lymphokines in different strains of mice.
    Neta R, Salvin SB.
    Cell Immunol; 1980 Apr 15; 51(1):173-8. PubMed ID: 6153932
    [No Abstract] [Full Text] [Related]

  • 15. Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP).
    Kato K, Yamamoto K, Kimura T, Azuma I, Askenase PW.
    J Immunol; 1984 Jun 15; 132(6):2790-5. PubMed ID: 6202761
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell.
    Klimpel GR, Okada M, Henney CS.
    J Immunol; 1979 Jul 15; 123(1):350-7. PubMed ID: 156233
    [No Abstract] [Full Text] [Related]

  • 17. Lymphoid sources of murine migration inhibition factor.
    Adelman NE, Ksiazek J, Yoshida T, Cohen S.
    J Immunol; 1980 Feb 15; 124(2):825-30. PubMed ID: 6985938
    [No Abstract] [Full Text] [Related]

  • 18. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice.
    Gros P, Skamene E, Forget A.
    J Immunol; 1981 Dec 15; 127(6):2417-21. PubMed ID: 6795274
    [Abstract] [Full Text] [Related]

  • 19. [Genetic control of production of a lymphokine inhibiting macrophage migration in mice].
    Petrov RV, Koval'chuk LV, Sokolova EV, Burtseva LV.
    Genetika; 1980 Dec 15; 16(10):1825-33. PubMed ID: 7007159
    [Abstract] [Full Text] [Related]

  • 20. Strain variation in interferon gamma production of BCG-sensitized mice challenged with PPD. I. CBA/Ca mice are low producers in vivo, but high producers in vitro.
    Huygen K, Palfliet K.
    Cell Immunol; 1983 Sep 15; 80(2):329-34. PubMed ID: 6411357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.